A detailed history of Man Group PLC transactions in Organon & Co. stock. As of the latest transaction made, Man Group PLC holds 131,437 shares of OGN stock, worth $1.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
131,437
Previous 116,704 12.62%
Holding current value
$1.96 Million
Previous $2.42 Million 4.1%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $274,770 - $339,300
14,733 Added 12.62%
131,437 $2.51 Million
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $1.47 Million - $1.85 Million
84,328 Added 260.46%
116,704 $2.42 Million
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $30,646 - $41,811
2,224 Added 7.38%
32,376 $608,000
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $275,929 - $436,446
-25,199 Reduced 45.53%
30,152 $434,000
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $5.76 Million - $8.26 Million
-347,372 Reduced 86.26%
55,351 $960,000
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $7.76 Million - $9.92 Million
402,723 New
402,723 $8.38 Million
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $2.61 Million - $3.21 Million
-82,416 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $1.42 Million - $1.84 Million
46,704 Added 130.78%
82,416 $2.88 Million
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $300,146 - $388,713
10,469 Added 41.47%
35,712 $1.09 Million
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $298,324 - $371,368
10,420 Added 70.3%
25,243 $828,000
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $421,714 - $563,274
14,823 New
14,823 $448,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.79B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.